Wenhao Hu[Author] - Search Results

Year	Number of Results
2002	3
2003	8
2004	10
2005	2
2006	3
2007	4
2008	5
2009	4
2010	8
2011	9
2012	7
2013	17
2014	19
2015	14
2016	20
2017	16
2018	23
2019	42
2020	43
2021	23
2022	27
2023	35
2024	9

1

Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer.

Weng W, Meng T, Zhao Q, Shen Y, Fu G, Shi J, Zhang Y, Wang Z, Wang M, Pan R, Ma L, Chen C, Wang L, Zhou B, Zhang H, Pu J, Zhang J, Hu YP, Hua G, Qian Y, Liu SH, Hu W, Meng X. Weng W, et al. Among authors: hu w. Cancer Discov. 2023 Apr 3;13(4):950-973. doi: 10.1158/2159-8290.CD-22-1368. Cancer Discov. 2023. PMID: 36693125

2

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).

Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ; CHANCE001 Investigators. Zhu HD, et al. Signal Transduct Target Ther. 2023 Feb 8;8(1):58. doi: 10.1038/s41392-022-01235-0. Signal Transduct Target Ther. 2023. PMID: 36750721 Free PMC article.

3

AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors.

Weng W, Meng T, Pu J, Ma L, Shen Y, Wang Z, Pan R, Wang M, Chen C, Wang L, Zhang J, Zhou B, Shao S, Qian Y, Liu S, Hu W, Meng X. Weng W, et al. Among authors: hu w. Mol Cancer Ther. 2023 Sep 5;22(9):1013-1027. doi: 10.1158/1535-7163.MCT-23-0198. Mol Cancer Ther. 2023. PMID: 37302522 Free PMC article.

4

MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors.

Kong C, Pu J, Zhao Q, Weng W, Ma L, Qian Y, Hu W, Meng X, Meng T. Kong C, et al. Among authors: hu w. Mol Cancer Ther. 2023 Oct 2;22(10):1128-1143. doi: 10.1158/1535-7163.MCT-23-0164. Mol Cancer Ther. 2023. PMID: 37352387 Free PMC article.

5

A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance.

Zheng Q, Dong H, Mo J, Zhang Y, Huang J, Ouyang S, Shi S, Zhu K, Qu X, Hu W, Liu P, Wang Y, Zhang X. Zheng Q, et al. Among authors: hu w. Theranostics. 2021 Jan 1;11(2):824-840. doi: 10.7150/thno.49600. eCollection 2021. Theranostics. 2021. PMID: 33391507 Free PMC article.

6

Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.

Liou JM, Jiang XT, Chen CC, Luo JC, Bair MJ, Chen PY, Chou CK, Fang YJ, Chen MJ, Chen CC, Lee JY, Yang TH, Yu CC, Kuo CC, Chiu MC, Chen CY, Shun CT, Hu WH, Tsai MH, Hsu YC, Tseng CH, Chang CY, Lin JT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Liou JM, et al. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):228-241. doi: 10.1016/S2468-1253(22)00384-3. Epub 2022 Dec 19. Lancet Gastroenterol Hepatol. 2023. PMID: 36549320 Clinical Trial.

7

A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma.

Shi J, Jiao T, Guo Q, Weng W, Ma L, Zhang Q, Wang L, Zhang J, Chen C, Huang Y, Wang M, Pan R, Tang Y, Hu W, Meng T, Liu SH, Guo J, Kong Y, Meng X. Shi J, et al. Among authors: hu w. Cancer Res. 2023 Nov 15;83(22):3783-3795. doi: 10.1158/0008-5472.CAN-23-1356. Cancer Res. 2023. PMID: 37668527 Free PMC article.

8

Enantioselective Multifunctionalization with Rh Carbynoids.

Qian Y, Tang J, Zhou X, Luo J, Yang X, Ke Z, Hu W. Qian Y, et al. Among authors: hu w. J Am Chem Soc. 2023 Dec 6;145(48):26403-26411. doi: 10.1021/jacs.3c10460. Epub 2023 Nov 22. J Am Chem Soc. 2023. PMID: 37993266

9

3-Diazo-N-[(2S)-1-hy-droxy-propan-2-yl]-2-oxopropanamide.

Chen XN, Hu WH, Li XL, Xu HD. Chen XN, et al. Acta Crystallogr Sect E Struct Rep Online. 2011 May 1;67(Pt 5):o1192. doi: 10.1107/S1600536811014413. Epub 2011 Apr 22. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21754494 Free PMC article.

10

Catalytic Asymmetric P-H Insertion Reactions.

Gu X, Mo X, Bai WJ, Xie P, Hu W, Jiang J. Gu X, et al. Among authors: hu w. J Am Chem Soc. 2023 Sep 13;145(36):20031-20040. doi: 10.1021/jacs.3c06906. Epub 2023 Aug 29. J Am Chem Soc. 2023. PMID: 37642381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

317 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Results by year